Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| M.A. Eloteify | UNKNOWN |
| Ahmed Kamal Osman | UNKNOWN |
| G.M. Hafsa | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
The Objectives of this randomized controlled trial aiming to establishing a protocol of post scar revision care and to Study the effect of PRP and/or Adipose derived Mesenchymal Stem cell injection in improvement of atrophic scar after scar revision.
Forty patients with atrophic scar since one to five years including 25 males and 15 females with ages ranging from ten to 35 years with main age of 22.68 will be divided into four groups each included ten patients. One group will be treated with scar revision only (control group or group I), 2nd group will be injected with PRP after scar revision, 3rd group will be injected with ADSCs after scar revision and the 4th group will be injected with a combination of PRP and ADSCs after scar revision. All groups were assisted pre-operative and six months post-operative. Complications, Scar width, Vancouver scar scale (VSS), surgeon assessment scar scale and patient assessment scar scale will be considered the outcome measurements.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| stem cell, PRP | Active Comparator | Adipose derived MSCs, versus Platelet rich plasma |
|
| Stem cell, Stem cell and PRP | Active Comparator | Adipose derived MSCs alone, other group is injected Adipose derived MSCs, and Platelet rich plasma |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Stem cell | Biological | after scar revision PRP is injected intradermally, also adipose derived mesenchymal stem cells |
|
| Measure | Description | Time Frame |
|---|---|---|
| Patient satisfaction (Patient Assessment Scar Scale) | Patient Assessment Scar Scale | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Doctor satisfaction (Vancouver Scar Scale) | Vancouver Scar Scale (VSS) | 6 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
randomized controlled trial
Not provided
Not provided
Not provided
Not provided
|
| MSCs | Device | manual separation of platelets rich plasma and undifferentiated mesenchymal stem cells |
|
|